The Latest Breaking News from SWAV

Futures signaled sharp losses for the market rally amid weak JPMorgan earnings and views for a massive Fed rate hike. Tesla's AI chief has left.

According to Benzinga Pro, during Q1, ShockWave Medical (NASDAQ:SWAV) earned $14.52 million, a 12.2% increase from the preceding quarter. ShockWave Medical also posted a total of $93.63 million in sales, a 11.22% increase since Q4.

Over the past 3 months, 6 analysts have published their opinion on ShockWave Medical (NASDAQ:SWAV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Shockwave Medical Inc (NASDAQ:SWAV) reported first-quarter revenue of $93.63 million, an increase of 193.5% year-over-year, beating the consensus of $86.41 million. The gross margin for Q1 expanded to 86.2% from 75.3% in 1Q21. The operating income for the quarter totaled $15.37 million versus a loss of $(17.48) million a year ago. EPS…